TY - JOUR
T1 - Practical considerations for omics experiments in biomedical sciences
AU - Vaudel, Marc
AU - Barsnes, Harald
AU - Bjerkvig, Rolf
AU - Bikfalvi, Andreas
AU - Selheim, Frode
AU - Berven, Frode S.
AU - Daubon, Thomas
N1 - Publisher Copyright:
© 2016 Bentham Science Publishers.
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Modern analytical techniques provide an unprecedented insight to biomedical samples, allowing an in depth characterization of cells or body fluids, to the level of genes, transcripts, peptides, proteins, metabolites, or metallic ions. The fine grained picture provided by such approaches holds the promise for a better understanding of complex pathologies, and consequently the personalization of diagnosis, prognosis and treatment procedures. In practice however, technical limitations restrict the resolution of the acquired data, and thus of downstream biomedical inference. As a result, the study of complex diseases like leukemia and other types of cancer is impaired by the high heterogeneity of pathologies as well as patient profiles. In this review, we propose an introduction to the general approach of characterizing samples and inferring biomedical results. We highlight the main limitations of the technique with regards to complex and heterogeneous pathologies, and provide ways to overcome these by improving the ability of experiments in discriminating samples.
AB - Modern analytical techniques provide an unprecedented insight to biomedical samples, allowing an in depth characterization of cells or body fluids, to the level of genes, transcripts, peptides, proteins, metabolites, or metallic ions. The fine grained picture provided by such approaches holds the promise for a better understanding of complex pathologies, and consequently the personalization of diagnosis, prognosis and treatment procedures. In practice however, technical limitations restrict the resolution of the acquired data, and thus of downstream biomedical inference. As a result, the study of complex diseases like leukemia and other types of cancer is impaired by the high heterogeneity of pathologies as well as patient profiles. In this review, we propose an introduction to the general approach of characterizing samples and inferring biomedical results. We highlight the main limitations of the technique with regards to complex and heterogeneous pathologies, and provide ways to overcome these by improving the ability of experiments in discriminating samples.
KW - Biomedical data interpretation
KW - High resolution medicine
KW - Omics
KW - Personalized medicine
KW - Systems biology
UR - http://www.scopus.com/inward/record.url?scp=84964697011&partnerID=8YFLogxK
U2 - 10.2174/1389201016666150817095348
DO - 10.2174/1389201016666150817095348
M3 - Article
C2 - 26278526
AN - SCOPUS:84964697011
SN - 1389-2010
VL - 17
SP - 105
EP - 114
JO - Current Pharmaceutical Biotechnology
JF - Current Pharmaceutical Biotechnology
IS - 1
ER -